Late in 2024 and early 2025, O2Bio marked major milestones in both financial growth and R&D positioning—evidencing its rising prominence in the clean-tech and biotech sectors.
Robust Financial Results for FY 2024
O2Bio announced a total revenue of ₩198 billion and a net profit of ₩16 billion in its 2024 fiscal results. This represents a 33% increase in total assets, bringing the balance sheet to approximately ₩174 billion.
These figures highlight strong market traction for its oxygen/nitrogen generation systems and its functional health products—demonstrating consumer trust and commercial scalability ahead of Series A funding and further institutional investments.
Strategic R&D Collaborations & Recognition
Also in late 2024, O2Bio gained attention through:
- Participation in the Inje University–led innovation ecosystem, including selection in the InnoPolis Campus prototype program alongside other regional startups
- Investment interest from the Inje Angel Investment Club and related institutions in August 2024
These initiatives reflect O2Bio’s dual approach: solidifying research credentials while integrating into regional innovation networks.
What This Means for O2Bio’s Future
- Financial strength enables accelerated product development, expanded production capacity, and entry into new markets.
- Institutional support and prototype validation pave the way for broader commercialization and enhanced investor confidence.
- Asset growth signals a robust operational platform, ready for scaling oxygen/nitrogen devices or functional health supplements.
Looking Ahead
Building on its impressive 2024 results and regional innovation ties, O2Bio is well-positioned to:
- Launch new portable oxygen/nitrogen models backed by further field trials and certifications
- Secure Series A funding, leveraging its strong revenue and low-cost innovations
- Increase outreach in healthcare, industrial, and agriculture verticals with proven commercial viability
In summary, O2Bio’s recent update marks a pivotal moment—transforming from a government-backed tech venture into a mature, financially-sound and innovation-driven enterprise with clear momentum toward global impact.